Reset
Id
Protein
PTM type
Site
Species
Disease
Cell line
Drug
Regulatory
Confidence score(level)
Ref.
acc2401 STAT6 phosphorylation Tyr641 human Breast Cancer EO771 Emodin Associated 4.0 (Moderate) 25311112
acc2402 H2AX methylation Lys134 human Breast Cancer MDA-MB-231 Doxorubicin Impairing 4.5 (High) 30159125
acc2403 H2AX phosphorylation Ser139 human Breast Cancer MDA-MB-231 Doxorubicin Impairing 4.5 (High) 30159125
acc2404 H2AX methylation Lys134 human Lung Cancer A549 Doxorubicin Impairing 4.5 (High) 30159125
acc2405 H2AX phosphorylation Ser139 human Lung Cancer A549 Doxorubicin Impairing 4.5 (High) 30159125
acc2406 H2AX methylation Lys134 human Breast Cancer MDA-MB-231 OTS193320 Associated 3.0 (Low) 30159125
acc2407 H2AX phosphorylation Ser139 human Breast Cancer MDA-MB-231 OTS193320 Associated 3.0 (Low) 30159125
acc2408 H2AX methylation Lys134 human Lung Cancer A549 OTS193320 Associated 3.0 (Low) 30159125
acc2409 H2AX phosphorylation Ser139 human Lung Cancer A549 OTS193320 Associated 3.0 (Low) 30159125
acc2410 YAP phosphorylation Ser127 human Pancreas Cancer PANC-1 Gemcitabine Impairing 5.0 (High) 31627466
acc2411 YAP phosphorylation Ser127 human Pancreas Cancer BxPC-3 Gemcitabine Impairing 5.0 (High) 31627466
acc2412 YAP phosphorylation Ser127 human Pancreas Cancer ASPC-1 Gemcitabine Impairing 5.0 (High) 31627466
acc2413 Bcl-2 phosphorylation unclear human Lung Cancer H5800 Cisplatin Enhancing 5.0 (High) 24548862
acc2414 Bcl-2 phosphorylation unclear mouse Lung Cancer LKR Cisplatin Enhancing 5.0 (High) 24548862
acc2415 Beclin-1 ubiquitination Ser90 human Myeloma KMS11 BTZ Impairing 5.0 (High) 31955515
acc2416 Beclin-1 ubiquitination Ser90 human Myeloma RPMI8226 BTZ Impairing 5.0 (High) 31955515
acc2417 Beclin-1 ubiquitination Ser93 human Myeloma KMS11 BTZ Impairing 5.0 (High) 31955515
acc2418 Beclin-1 ubiquitination Ser93 human Myeloma RPMI8226 BTZ Impairing 5.0 (High) 31955515
acc2419 Beclin-1 ubiquitination Ser96 human Myeloma KMS11 BTZ Impairing 5.0 (High) 31955515
acc2420 Beclin-1 ubiquitination Ser96 human Myeloma RPMI8226 BTZ Impairing 5.0 (High) 31955515
acc2421 MRE11 ubiquitination Lys339 human Breast Cancer HCC1806 Radiotherapy Enhancing 5.0 (High) 36563124
acc2422 MRE11 ubiquitination Lys339 human Breast Cancer MDA-MB-231 Radiotherapy Enhancing 5.0 (High) 36563124
acc2423 MRE11 ubiquitination Lys480 human Breast Cancer HCC1806 Radiotherapy Enhancing 5.0 (High) 36563124
acc2424 MRE11 ubiquitination Lys480 human Breast Cancer MDA-MB-231 Radiotherapy Enhancing 5.0 (High) 36563124
acc2425 RIPK1 ubiquitination unclear human Leukemia MT4 Birinapant Associated 4.0 (Moderate) 32024820
acc2426 CYLD phosphorylation Ser418 human Leukemia MT4 Birinapant Associated 4.0 (Moderate) 32024820
acc2427 RIPK1 ubiquitination unclear human Leukemia MT4 MRT67307 Associated 4.0 (Moderate) 32024820
acc2428 CYLD phosphorylation Ser418 human Leukemia MT4 MRT67307 Associated 4.0 (Moderate) 32024820
acc2429 RIPK1 ubiquitination unclear human Leukemia MT4 TPCA Associated 4.0 (Moderate) 32024820
acc2430 CYLD phosphorylation Ser418 human Leukemia MT4 TPCA Associated 4.0 (Moderate) 32024820
acc2431 ERK1 phosphorylation Thr202 human Hepatocellular Carcinoma Hep3B EGCG Associated 4.0 (Moderate) 19360302
acc2432 ERK1 phosphorylation Tyr204 human Hepatocellular Carcinoma Hep3B EGCG Associated 4.0 (Moderate) 19360302
acc2433 ERK2 phosphorylation Thr185 human Hepatocellular Carcinoma Hep3B EGCG Associated 4.0 (Moderate) 19360302
acc2434 ERK2 phosphorylation Tyr187 human Hepatocellular Carcinoma Hep3B EGCG Associated 4.0 (Moderate) 19360302
acc2435 NFKBIA phosphorylation Ser32 human Myeloma MM.1S PS-1145 Associated 4.0 (Moderate) 11872748
acc2436 NFKBIA phosphorylation Ser32 human Myeloma RPMI8226 PS-1145 Associated 4.0 (Moderate) 11872748
acc2437 NFKBIA phosphorylation Ser32 human Myeloma U266 PS-1145 Associated 4.0 (Moderate) 11872748
acc2438 NFKBIA phosphorylation Ser32 human Myeloma MM.1S PS-1145 + Dex Associated 4.0 (Moderate) 11872748
acc2439 TOPK phosphorylation Thr9 human Melanoma RPMI7951 arsenite Associated 4.0 (Moderate) 17145805
acc2440 H2AX phosphorylation Ser139 human Melanoma RPMI7951 arsenite Associated 3.0 (Low) 17145805
acc2441 AMPK phosphorylation Thr172 human Lung Cancer A549 TRAIL Impairing 5.0 (High) 29929000
acc2442 AMPK phosphorylation Thr183 human Lung Cancer A549 TRAIL Impairing 5.0 (High) 29929000
acc2443 AMPK phosphorylation Thr172 human Lung Cancer HCC-15 TRAIL Impairing 5.0 (High) 29929000
acc2444 AMPK phosphorylation Thr183 human Lung Cancer HCC-15 TRAIL Impairing 5.0 (High) 29929000
acc2445 JNK2 phosphorylation Thr183 human Colorectal Cancer HT29 TRAIL + 5-fluorouracil (5-FU) Enhancing 5.0 (High) 15837763
acc2446 JNK2 phosphorylation Thr183 human Hepatocellular Carcinoma HepG2 TRAIL + 5-fluorouracil (5-FU) Enhancing 5.0 (High) 15837763
acc2447 JNK2 phosphorylation Tyr185 human Colorectal Cancer HT29 TRAIL + 5-fluorouracil (5-FU) Enhancing 5.0 (High) 15837763
acc2448 JNK2 phosphorylation Tyr185 human Hepatocellular Carcinoma HepG2 TRAIL + 5-fluorouracil (5-FU) Enhancing 5.0 (High) 15837763
acc2449 JNK2 phosphorylation Thr183 human Colorectal Cancer HT29 TRAIL + Cisplatin Enhancing 5.0 (High) 15837763
acc2450 JNK2 phosphorylation Thr183 human Hepatocellular Carcinoma HepG2 TRAIL + Cisplatin Enhancing 5.0 (High) 15837763